Literature DB >> 33259086

Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.

Sunjae Bae1,2,3, Jacqueline M Garonzik-Wang1, Allan B Massie1,2, Mara A McAdams-DeMarco1,2, Josef Coresh2,3,4, Dorry L Segev1,2.   

Abstract

BACKGROUND: Approximately 30% of kidney transplant recipients undergo early steroid withdrawal (ESW) for maintenance immunosuppression. However, there is no consensus on which patients are suitable for ESW, and transplant centers may disagree on how various clinical factors characterize individual recipients' suitability for ESW.
METHODS: To examine center-level variation in the association of clinical factors with the choice of ESW, we studied 206 544 kidney transplant recipients from 278 centers in 2002-2017 using SRTR data. We conducted multi-level logistic regressions to characterize the association of clinical factors with the choice of ESW at each transplant center.
RESULTS: The association of clinical factors with the choice of ESW varied substantially across centers. We found particularly greater inconsistency in recipient age, PRA, re-transplantation, living/deceased donor, post-transplant length of stay, and delayed graft function. For example, across the entire population, re-transplantation was associated with lower odds of ESW (population odds ratio = 0.35 0.400.46 ). When estimated at each center, this odds ratio was significantly lower than the population odds ratio at 48 (17.3%) centers and significantly higher at 28 (10.1%) centers.
CONCLUSIONS: We have observed apparent inconsistencies across transplant centers in the practice of tailoring ESW to the recipient's risk profile. Standardized guidelines for ESW tailoring are needed.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  immunosuppression; kidney transplantation; practice; variation

Mesh:

Substances:

Year:  2020        PMID: 33259086      PMCID: PMC8284554          DOI: 10.1111/ctr.14176

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  37 in total

1.  Steroid withdrawal for the (selected) masses.

Authors:  Donald E Hricik
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

2.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

3.  KDIGO clinical practice guideline for the care of kidney transplant recipients.

Authors: 
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

4.  Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure.

Authors:  Suphamai Bunnapradist; Krista L Lentine; Thomas E Burroughs; Brett W Pinsky; Karen L Hardinger; Daniel C Brennan; Mark A Schnitzler
Journal:  Transplantation       Date:  2006-07-15       Impact factor: 4.939

5.  Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.

Authors:  Jordana B Cohen; Kevin C Eddinger; Kimberly A Forde; Peter L Abt; Deirdre Sawinski
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

6.  Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.

Authors:  Vikas R Dharnidharka; Mark A Schnitzler; Jiajing Chen; Daniel C Brennan; David Axelrod; Dorry L Segev; Kenneth B Schechtman; Jie Zheng; Krista L Lentine
Journal:  Transpl Int       Date:  2016-09-28       Impact factor: 3.782

7.  Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.

Authors:  Diego Cantarovich; Lionel Rostaing; Nassim Kamar; Yves Saint-Hillier; Didier Ducloux; Georges Mourad; Valérie Garrigue; Philippe Wolf; Bernard Ellero; Elizabeth Cassuto; Laetitia Albano; Jean-Paul Soulillou
Journal:  Transpl Int       Date:  2009-10-19       Impact factor: 3.782

8.  A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.

Authors:  E Steve Woodle; M Roy First; John Pirsch; Fuad Shihab; A Osama Gaber; Paul Van Veldhuisen
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

9.  Weight trimming and propensity score weighting.

Authors:  Brian K Lee; Justin Lessler; Elizabeth A Stuart
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 10.  Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Authors:  Peter C Austin; Elizabeth A Stuart
Journal:  Stat Med       Date:  2015-08-03       Impact factor: 2.373

View more
  1 in total

1.  Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients.

Authors:  David A Axelrod; Wisit Cheungpasitporn; Suphamai Bunnapradist; Mark A Schnitzler; Huiling Xiao; Mara McAdams-DeMarco; Yasar Caliskan; Sunjae Bae; JiYoon B Ahn; Dorry L Segev; Ngan N Lam; Gregory P Hess; Krista L Lentine
Journal:  Kidney Med       Date:  2021-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.